BLVRA

UniProt ID: P53004
Organism: Homo sapiens
Review Status: INITIALIZED
πŸ“ Provide Detailed Feedback

Gene Description

BLVRA (biliverdin reductase A, BVR-A; EC 1.3.1.24) is a soluble cytosolic NAD(P)H-dependent oxidoreductase that catalyzes the second and terminal step of heme catabolism: reduction of the gamma-methene bridge of biliverdin IX-alpha to bilirubin IX-alpha, the yellow, lipophilic, potently antioxidant bile pigment. It acts downstream of heme oxygenase (HMOX1/HMOX2), which cleaves heme to biliverdin. BVR-A is unusual among enzymes in having dual cofactor and dual pH specificity: it uses NADH at acidic pH and NADPH at alkaline pH, with NADPH the probable physiological electron donor. The enzyme is specific for the IX-alpha isomer (the IX-beta isomer is handled by the paralog BLVRB) and adopts a Gfo/Idh/MocA-family fold with an N-terminal NAD(P)-binding Rossmann domain. It is broadly expressed, with high activity in liver. Beyond its metabolic role, human BVR-A moonlights as a dual-specificity Ser/Thr/Tyr protein kinase and signaling scaffold that participates in insulin/IGF1, PKC, PI3K and MAPK/ERK signaling, functioning as an ERK activator and nuclear transporter and thereby linking cytoplasmic signaling to gene regulation. Loss-of-function variants cause hyperbiliverdinemia (green jaundice), a green discoloration of skin and body fluids that typically manifests in the setting of obstructive cholestasis or liver failure.

Existing Annotations Review

GO Term Evidence Action Reason
GO:0004074 biliverdin reductase [NAD(P)H] activity
IBA
GO_REF:0000033
ACCEPT
Summary: Core molecular function of BLVRA, propagated by phylogenetic inference from the biliverdin reductase family tree (PANTHER PTN008681150). Fully consistent with the direct experimental characterization of the human enzyme.
Supporting Evidence:
file:human/BLVRA/BLVRA-uniprot.txt
Reduces the gamma-methene bridge of the open tetrapyrrole, biliverdin IXalpha, to bilirubin with the concomitant oxidation of a NADH or NADPH cofactor
GO:0000166 nucleotide binding
IEA
GO_REF:0000002
KEEP AS NON CORE
Summary: Generic InterPro-derived binding term reflecting the NAD(P)-binding Rossmann domain. True but uninformative on its own; it describes a substructure of the catalytic mechanism rather than a distinct function. Keep as non-core.
Supporting Evidence:
file:human/BLVRA/BLVRA-uniprot.txt
KM=3.2 uM for NADPH
GO:0004074 biliverdin reductase [NAD(P)H] activity
IEA
GO_REF:0000120
ACCEPT
Summary: Electronic annotation of the core MF via InterPro/EC mapping (EC:1.3.1.24). Agrees with the experimental IDA annotations; retained as core.
Supporting Evidence:
file:human/BLVRA/BLVRA-uniprot.txt
Reduces the gamma-methene bridge of the open tetrapyrrole, biliverdin IXalpha, to bilirubin with the concomitant oxidation of a NADH or NADPH cofactor
GO:0005737 cytoplasm
IEA
GO_REF:0000002
KEEP AS NON CORE
Summary: Correct but less specific than the experimentally supported cytosol annotation. The enzyme is a soluble cytosolic protein; keep as non-core in favor of the more precise GO:0005829 (cytosol).
Supporting Evidence:
file:human/BLVRA/BLVRA-uniprot.txt
Cytoplasm, cytosol
GO:0005829 cytosol
IEA
GO_REF:0000044
ACCEPT
Summary: Electronic subcellular-location annotation consistent with experimental IDA evidence that BVR-A is a cytosolic enzyme. Retained as the functional location.
Supporting Evidence:
file:human/BLVRA/BLVRA-uniprot.txt
Cytoplasm, cytosol
GO:0008270 zinc ion binding
IEA
GO_REF:0000002
KEEP AS NON CORE
Summary: BVR-A purified from human liver contains ~1 Zn per subunit and exogenous Zn inhibits the NADPH-dependent (but not NADH-dependent) activity, so zinc binding is real. However UniProt records the cofactor/binding assignment as an inference (ECO:0000305/ECO:0000303) and the crystal structure (2H63) is NADP-bound without a modeled zinc; its physiological requirement is not fully established. Keep as a non-core cofactor-binding attribute rather than a core MF.
Supporting Evidence:
file:human/BLVRA/BLVRA-uniprot.txt
Binds 1 zinc ion per subunit.
GO:0042167 heme catabolic process
IEA
GO_REF:0000002
ACCEPT
Summary: Core biological process: BVR-A performs the terminal reduction step of the heme degradation pathway. Electronic annotation agrees with the experimental IDA annotation to the same term.
Supporting Evidence:
file:human/BLVRA/BLVRA-uniprot.txt
Porphyrin-containing compound metabolism; protoheme
GO:0106276 biliberdin reductase (NADH) activity
IEA
GO_REF:0000120
ACCEPT
Summary: NADH-specific child of the core biliverdin reductase activity. Electronic (Rhea/ARBA) annotation matching the experimentally demonstrated NADH-dependent activity at acidic pH; retained.
Supporting Evidence:
file:human/BLVRA/BLVRA-uniprot.txt
Uses the reactants NADH or NADPH depending on the
GO:0106277 biliverdin reductase (NADPH) activity
IEA
GO_REF:0000116
ACCEPT
Summary: NADPH-specific child of the core activity (NADPH is the probable physiological cofactor). Electronic Rhea annotation agreeing with experimental EXP/IDA evidence; retained.
Supporting Evidence:
file:human/BLVRA/BLVRA-uniprot.txt
NADPH, however, is the probable reactant in biological
GO:0005515 protein binding
IPI
PMID:18463290
Human biliverdin reductase is an ERK activator; hBVR is an E...
MARK AS OVER ANNOTATED
Summary: IPI capturing the BVR-A interaction with MAPK1/ERK2 (UniProtKB:P28482), which underlies the moonlighting ERK-scaffold function. Real and mechanistically meaningful, but the bare "protein binding" term is uninformative; the specific function is better represented by the protein serine/threonine kinase / ERK-scaffold core function. Not removed (experimental IPI); flagged as over-annotation of the generic term.
Supporting Evidence:
PMID:18463290
Human biliverdin reductase (hBVR) is a recently described Ser/Thr/Tyr kinase in the MAPK insulin/insulin-like growth factor 1 (IGF1)-signaling cascade
GO:0005515 protein binding
IPI
PMID:25416956
A proteome-scale map of the human interactome network.
MARK AS OVER ANNOTATED
Summary: IPI from a large-scale human interactome map recording an interaction with LNX1 (UniProtKB:Q8TBB1). Bare "protein binding" is uninformative and the biological significance of this high-throughput interaction is unclear. Not removed (experimental IPI); marked as over-annotation.
GO:0005515 protein binding
IPI
PMID:29892012
An interactome perturbation framework prioritizes damaging m...
MARK AS OVER ANNOTATED
Summary: IPI from an interactome-perturbation study, again recording the LNX1 (Q8TBB1) interaction. Uninformative bare protein-binding term; not removed (experimental IPI) but marked as over-annotation.
GO:0005515 protein binding
IPI
PMID:31515488
Extensive disruption of protein interactions by genetic vari...
MARK AS OVER ANNOTATED
Summary: IPI from a large-scale variant-interaction study, LNX1 (Q8TBB1) partner. Bare protein binding; not removed (experimental IPI) but marked as over-annotation of an uninformative generic term.
GO:0005829 cytosol
IDA
GO_REF:0000052
ACCEPT
Summary: Immunofluorescence-based (HPA) localization to the cytosol, consistent with the biochemically established cytosolic localization of BVR-A. Accepted as the functional location.
Supporting Evidence:
file:human/BLVRA/BLVRA-uniprot.txt
Cytoplasm, cytosol
GO:0106276 biliberdin reductase (NADH) activity
EXP
PMID:10858451
Studies on the specificity of the tetrapyrrole substrate for...
ACCEPT
Summary: Experimental (EXP) support for the NADH-dependent biliverdin reductase activity, from kinetic characterization of the human enzyme. Core catalytic function; accepted.
Supporting Evidence:
file:human/BLVRA/BLVRA-uniprot.txt
Uses the reactants NADH or NADPH depending on the
GO:0106277 biliverdin reductase (NADPH) activity
EXP
PMID:10858451
Studies on the specificity of the tetrapyrrole substrate for...
ACCEPT
Summary: Experimental support for the NADPH-dependent biliverdin reductase activity. NADPH is the probable physiological cofactor. Core catalytic function; accepted.
Supporting Evidence:
file:human/BLVRA/BLVRA-uniprot.txt
NADPH, however, is the probable reactant in biological
GO:0106277 biliverdin reductase (NADPH) activity
EXP
PMID:7929092
Biliverdin-IX alpha reductase and biliverdin-IX beta reducta...
ACCEPT
Summary: Experimental support from purification of human liver biliverdin-IX alpha reductase; NADPH assumed to be the physiological electron donor. Core catalytic function; accepted.
Supporting Evidence:
PMID:7929092
It was assumed that NADPH rather than NADH was the
GO:0106277 biliverdin reductase (NADPH) activity
EXP
PMID:8424666
Purification and characterization of human biliverdin reduct...
ACCEPT
Summary: Experimental support from purification/characterization of human biliverdin reductase, showing dual cofactor use with NADPH preferred at alkaline pH. Core catalytic function; accepted.
Supporting Evidence:
PMID:8424666
At pH 6.0-7.0 the NADH was the more effective cofactor, whereas at pH
GO:0106277 biliverdin reductase (NADPH) activity
EXP
PMID:8631357
Human biliverdin IXalpha reductase is a zinc-metalloprotein....
ACCEPT
Summary: Experimental support from characterization of purified and recombinant human BVR-A, demonstrating dual pH/cofactor specificity including NADPH use. Core catalytic function; accepted.
Supporting Evidence:
PMID:8631357
BVR is unique among enzymes characterized to date in that it has dual pH/cofactor (NADH, NADPH) specificity
GO:0004074 biliverdin reductase [NAD(P)H] activity
IDA
PMID:7929092
Biliverdin-IX alpha reductase and biliverdin-IX beta reducta...
ACCEPT
Summary: Direct assay of purified human liver biliverdin-IX alpha reductase. This is a primary line of experimental evidence for the core molecular function; accepted.
Supporting Evidence:
PMID:7929092
isozymes III and IV preferred biliverdin-IX
GO:0004074 biliverdin reductase [NAD(P)H] activity
IDA
PMID:8424666
Purification and characterization of human biliverdin reduct...
ACCEPT
Summary: Direct experimental demonstration that the purified human liver enzyme converts biliverdin to bilirubin. Core molecular function; accepted.
Supporting Evidence:
PMID:8424666
Conversion of biliverdin to bilirubin is catalyzed by the cytosolic enzyme biliverdin reductase
GO:0004074 biliverdin reductase [NAD(P)H] activity
IDA
PMID:8631357
Human biliverdin IXalpha reductase is a zinc-metalloprotein....
ACCEPT
Summary: Direct assay of purified and E. coli-expressed human BVR-A converting biliverdin to bilirubin. Core molecular function; accepted.
Supporting Evidence:
PMID:8631357
Biliverdin IXalpha reductase (BVR) catalyzes the conversion of the heme b degradation product, biliverdin, to bilirubin
GO:0005829 cytosol
IDA
PMID:7929092
Biliverdin-IX alpha reductase and biliverdin-IX beta reducta...
ACCEPT
Summary: BVR-A activity was isolated from human liver cytosolic fractions, establishing the cytosol as the site of the catalytic activity (is_active_in). Accepted as the functional location.
Supporting Evidence:
PMID:7929092
in human liver cytosolic
GO:0005829 cytosol
IDA
PMID:8424666
Purification and characterization of human biliverdin reduct...
ACCEPT
Summary: Experimental evidence that biliverdin-to-bilirubin conversion is catalyzed by the cytosolic enzyme, supporting cytosol as the active-in location. Accepted.
Supporting Evidence:
PMID:8424666
catalyzed by the cytosolic enzyme
GO:0106276 biliberdin reductase (NADH) activity
IDA
PMID:7929092
Biliverdin-IX alpha reductase and biliverdin-IX beta reducta...
ACCEPT
Summary: Direct evidence that the purified human enzyme uses NADH as an electron donor for biliverdin reduction. NADH-specific child of the core activity; accepted.
Supporting Evidence:
PMID:7929092
The purified enzymes used NADPH and NADH as electron donors for the reduction of biliverdin
GO:0106276 biliberdin reductase (NADH) activity
IDA
PMID:8424666
Purification and characterization of human biliverdin reduct...
ACCEPT
Summary: Direct evidence for NADH-dependent activity (more effective cofactor at acidic pH). NADH-specific child of the core biliverdin reductase activity; accepted.
Supporting Evidence:
PMID:8424666
At pH 6.0-7.0 the NADH was the more effective cofactor
GO:0106276 biliberdin reductase (NADH) activity
IDA
PMID:8631357
Human biliverdin IXalpha reductase is a zinc-metalloprotein....
ACCEPT
Summary: Direct evidence for NADH-dependent activity as part of the demonstrated dual pH/cofactor specificity of human BVR-A. NADH-specific child of core activity; accepted.
Supporting Evidence:
PMID:8631357
the human enzyme may also use NADH as cofactor
GO:0042167 heme catabolic process
IDA
PMID:10858451
Studies on the specificity of the tetrapyrrole substrate for...
ACCEPT
Summary: BVR-A performs the terminal reduction step of heme catabolism, converting biliverdin IX-alpha to bilirubin. Core biological process; accepted.
Supporting Evidence:
file:human/BLVRA/BLVRA-uniprot.txt
Reduces the gamma-methene bridge of the open tetrapyrrole, biliverdin IXalpha, to bilirubin
GO:0070062 extracellular exosome
HDA
PMID:19056867
Large-scale proteomics and phosphoproteomics of urinary exos...
KEEP AS NON CORE
Summary: High-throughput MS detection of BVR-A in urinary exosomes. BVR-A is a soluble cytosolic enzyme that is a common cargo of secreted vesicles; this does not reflect a functional extracellular location. Keep as non-core.
Supporting Evidence:
PMID:19056867
the analysis identified 1132 proteins unambiguously
GO:0070062 extracellular exosome
HDA
PMID:20458337
MHC class II-associated proteins in B-cell exosomes and pote...
KEEP AS NON CORE
Summary: High-throughput MS detection of BVR-A in B-cell-derived exosomes. As with the urinary-exosome dataset, this reflects vesicular cargo rather than a functional extracellular location. Keep as non-core.
Supporting Evidence:
PMID:20458337
highly purified B cell-derived exosomes
GO:0005829 cytosol
TAS
Reactome:R-HSA-189384
ACCEPT
Summary: Reactome traceable-author-statement placing the BLVRA-catalyzed biliverdin-to-bilirubin reaction in the cytosol. Consistent with experimental localization; accepted.
Supporting Evidence:
Reactome:R-HSA-189384
BIL is formed from the reduction of biliverdin (BV) by bilverdin reductases BLVRA and BLVRB
GO:0004074 biliverdin reductase [NAD(P)H] activity
IDA
PMID:10858451
Studies on the specificity of the tetrapyrrole substrate for...
ACCEPT
Summary: Direct kinetic characterization of the human biliverdin-IX alpha reductase substrate specificity, supporting the core molecular function. Accepted.
Supporting Evidence:
PMID:10858451
at least one "bridging propionate" is necessary for

Core Functions

Cytosolic NAD(P)H-dependent biliverdin reductase catalyzing the terminal step of heme catabolism: reduction of biliverdin IX-alpha to bilirubin IX-alpha, using NADH at acidic pH and NADPH (the probable physiological cofactor) at alkaline pH. Specific for the IX-alpha isomer.

Directly Involved In:
Cellular Locations:
Supporting Evidence:
  • file:human/BLVRA/BLVRA-uniprot.txt
    Reduces the gamma-methene bridge of the open tetrapyrrole, biliverdin IXalpha, to bilirubin with the concomitant oxidation of a NADH or NADPH cofactor
  • PMID:8631357
    Biliverdin IXalpha reductase (BVR) catalyzes the conversion of the heme b degradation product, biliverdin, to bilirubin

References

Loading supporting content…

Download this section (compressed HTML)

πŸ“š Additional Documentation

Notes

(BLVRA-notes.md)

Loading supporting content…

Download this section (compressed HTML)

πŸ“„ View Raw YAML

Loading supporting content…

Download this section (compressed HTML)